Next Gen Sequencing (NGS) Market | USD 17.15 Billion 2024 | CAGR Of 18.6%

A Research Report On Next Generation Sequencing Market Comprising Of Market’s Current And Future Trends

The Next Gen Sequencing (NGS) Market Is Projected To Reach USD 17.15 Billion By 2024 From USD 5.13 Billion In 2017, At A CAGR Of 18.6% During The Forecast Period

Changing aspects of Next generation sequencing market
The global next generation sequencing market is growing due to following factors such as-
• Increase in gene mapping activities
• Affordable cost of sequencing and technological development in personalized medicine
• Adding to this, rise in R & D activities by market players, drug discovery applications
However, dearth for skilled professionals, storage and management of patient data and ethical and legal issues related to the practices will hamper the next generation sequencing market.
Request Sample Report : https://bit.ly/2KXG7GN
Regional analysis:
North America is anticipated to hold the largest share due to increased R & D activities for proteomic and genomic sequence, rise in adoption of next generation sequence techniques is helping to grow the market. Moreover, countries such as U.S., U.K. and Germany which are offering courses related to molecular biology which is also help to grow the next generation sequence market.
Asia-Pacific is growing at faster rate in the global next generation sequencing market due to factors such as rising awareness about medical opportunities, increasing government initiatives and rise in partnerships and agreements among market players.
Market summary:
Local and international market players are actively involved in research, development and marketing of next generation sequencing market. Growing acquisitions, partnerships, collaborations and mergers are adopted by research laboratories and academic institutes and innovative products by market players are fueling the market of next-generation sequencing market. In addition to this, scientists and drug developers are working towards development of personalized medicine in order to boost the next generation sequencing market.
Notable market development:
Together with Amgen, Illumina’s next-generation sequencing cancer companion diagnostic test kit was FDA approved in 2017.

Some of the players in global next-generation sequencing market are
• Agilent Technologies, Inc. (U.S.)
• Illumina, Inc. (U.S.)
• Pacific Biosciences (Danaher Corporation) (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Qiagen N. V. (Germany)
• Beijing Genomics Institute (China)
• PerkinElmer, Inc (U.S.)
• F. Hoffmann La Roche AG (Switzerland)
• Genomatix GmbH (Germany)
• Oxford Nanopore Technologies (U.K.)
• Eurofins Scientific (U.S.)

The global next generation sequencing market is divided into following categories-
By product and service type
• Pre-sequencing products and services market
o DNA fragmentation, size selection, A-tailing, and end repair
o Library preparation and target enrichment
o Quality control
• Sequencing services market
o Targeted sequencing/gene panels
o RNA-Seq
o De Novo sequencing
o Exome sequencing
o Chip-Seq
o Whole-genome sequencing
o Methyl-Seq
o others
• Next-generationn sequencing, data analysis, storage, and management (Bioinformatics) market
o NGS data analysis software & workbenches
o NGS data analysis services
o NGS storage management and cloud computing solutions

By technology
• Ion semiconductor sequencing
• Sequencing by the synthesis (SBS)
• Nanopore sequencing
• Single-molecule real-time (SMRT) sequencing

By application
• Drug discovery
• Diagnostics
• Agriculture and animal research
• Biomarker discovery
• Precision medicine
• Other applications

By end-users
• Biotechnology and Pharmaceutical Companies
• Research Centres
• Hospitals & Clinics
• Others

By geographical regions
• North America
• Latin America
• Europe
• Asia-Pacific
• The Middle East & Africa

For More Information: https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.